Neuroendocrine Aspects of Fibromyalgia

REFERENCES

• Chrousos GP, Gold PW: The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis. JAMA 267: 1244–1252, 1992.
   PubMed Web of Science ®Google Scholar
• Payne IC, Leavitt F, Garron DC, Katz RS, Golden HE, Glickman PB, Van-derplate C: Fibrositis and psychological disturb s e. Arthritis' -urn 25: 213–217, 1982.
   PubMed Web of Science ®Google Scholar
• Hudson 11, Hiner LF, Hudson MS, Goldenberg DL, Melby JC:dexa-methasone suppression test in fibrositis. Biol Psych 19: 1489–1493, 1984.
   PubMed Web of Science ®Google Scholar
• Ahles TA, Yunus 1., Riley SD, Bradley JM, Masi AT: Psychological factors associated with primary fibromyalgia1,1Arthritis '27:1101–1106, 1984.
   Google Scholar
• Clark S, C:1 pbell SM, Forehand I, Tindall EA, Bennett: Clinicalcharacteristics of fibrositis. Arthritis Rheum 28: 132–137, 1985.
   PubMed Web of Science ®Google Scholar
• Dailey PA, Bishop GD, Russell U, Fletcher EM: Psychological stress and the fibrositis/fibromyalgia syndrome. J Rheum 17: 1380–1385, 1990.
   PubMed Web of Science ®Google Scholar
• Kanner AD, Coyne JC, Schaefer C, Lararus RS: Comparison of two modes of stress measurement: Daily hassles and uplifts versus major life events. j Behav Med 4: 2–39, 1981.
   Google Scholar
• Hashimoto K, Suemaru S, Takao T, Sugawara M, Makino S, Ota Z: Corti-cotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats. Regulatory Peptides 23: 117–126, 1988.
   PubMedGoogle Scholar
• Scaccionoce S, Muscolo LAA, Cigliana G, Navarra D, Nicolai R, Ange-lucci L: Evidence for a specific role of vasopressin in sustaining pituitary-adreno-cortical stress response in the rat. Endocrinology 128: 3138–3143, 1991.
   PubMed Web of Science ®Google Scholar
• de Goeij DCE, Kvetnanslcy R, Whitnall MN, Jezova D, Berkenfiosch F, Tilders FJH: Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releas-ing factor in the median eminence of rats. Neuroendocrinology 53: 150–159, 1991.
   PubMed Web of Science ®Google Scholar
• Krieger DT, Rizzo F: Serotonin mediation of circadian periodicity of plas-ma 17-hydroxycorticosteroids. Am J Physiol 217: 1703–1707, 1969.
   PubMed Web of Science ®Google Scholar
• Scapagnini U, Mo b GP, Van Loon GR, de Groot J, Ganong WF: Rela-tion of brain 5-hydroxytryptamine content to the diurnal variation of plasma corti-costerone in the rat. Neuroendocrinology 7: 90–96, 1971.
   PubMed Web of Science ®Google Scholar
• Yehuda R, Meyer JS: A role for serotonin in the hypothalamic-pituitary-adrenal response to insulin stress. Neuroendocrinology 38: 25–32, 1984.
   PubMed Web of Science ®Google Scholar
• Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC: Plasma and urinary catecholarnines in primary fibromyalgia: A controlled study. J Rheum 19: 95–97, 1992.
   PubMed Web of Science ®Google Scholar
• McCain GA, Tilbe KS: Diurnal hormone variation in fibromyalgia syn-drome: A comparison with rheumatoid arthritis. J Rheum 16 (Supplement 19): 154–157, 1989.
   Google Scholar
• Ferraccioli G, Cavalieri F, Salaffi F, Fontana S, Scita F, Nolli M, Maestri D: Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain). J Rheum 19: 869–873, 1990.
   Google Scholar
• Crriep EN, Boersma JW, de Kloet EP: Altered reactivity of the hypothalam-ic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheum 20: 469–474, 1993.
   PubMedGoogle Scholar
• Demitrack, Dale JK, Straus SE, Laue L, Listwak SJ,esiChrousos GP, Gold PW: Evidence for impa s activation of the hypothalamic-pi-tuitary-adrenal axis in patients with chronic fatigue syndrome. J Clin End Metab 73: 1224–1234, 1991.
   PubMed Web of Science ®Google Scholar
• Moldofslcy H: Rheumatic pain modulation syndromes: The interrelation-ships between sleep, central nervous system, serotonin • pain. Adv Neurol 33: 51–57, 1982.
   PubMedGoogle Scholar
• Russell U: Neurohorrnonal aspects of fibromyalgia syndrome. Rhetun Dis Clin N Am 15: 149–168, 1989.
   PubMed Web of Science ®Google Scholar
• Disdier P, Harle J-R, Brue T, Jaquet P, Chambourlier P, Grisoli F, Weiller P-J: Severe fibromyalgia after hypophysectomy for Cushing's disease. Arthritis Rheum 34:493–495, 1991.
   PubMed Web of Science ®Google Scholar
• Vaeroy H, Helle R, Førre O, Kass E, Terenius L: Cerebrospinal fluid levels of/3-endorphin in patients with fibromyalgia (fibrositis syndrome). J Rheum 15: 1804–1806, 1988.
   PubMed Web of Science ®Google Scholar
• Sternberg EM: Hypoimmune fatigue syndromes: Diseases of the stress re-sponse? J Rheum 20:418–421, 1993.
   PubMed Web of Science ®Google Scholar
• Bennett ', Clark SR, Campbell SM, Burckhardt CS: Low levels of so-matomedin C in patients with the fibromyalgia syndrome. Arthritis Rheum 35: 1113–1116, 1992.
   Google Scholar